J 2018

Role of combined prenatal and postnatal paracetamol exposure on asthma development: the Czech ELSPAC study

PILER, Pavel, Jan ŠVANCARA, Lubomír KUKLA and Hynek PIKHART

Basic information

Original name

Role of combined prenatal and postnatal paracetamol exposure on asthma development: the Czech ELSPAC study

Authors

PILER, Pavel (203 Czech Republic, belonging to the institution), Jan ŠVANCARA (203 Czech Republic, belonging to the institution), Lubomír KUKLA (203 Czech Republic, belonging to the institution) and Hynek PIKHART (203 Czech Republic, guarantor, belonging to the institution)

Edition

Journal of Epidemiology and Community Health, LONDON, BMJ PUBLISHING GROUP, 2018, 0143-005X

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30304 Public and environmental health

Country of publisher

United Kingdom of Great Britain and Northern Ireland

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 3.872

RIV identification code

RIV/00216224:14310/18:00104779

Organization unit

Faculty of Science

UT WoS

000429428000014

Keywords in English

asthma; drug safety; cohort studies; epidemiology

Tags

Tags

International impact, Reviewed
Změněno: 9/1/2019 19:12, Mgr. Michaela Hylsová, Ph.D.

Abstract

V originále

Background Prenatal and postnatal paracetamol exposure has been previously associated with asthma development in childhood in Western populations. We explore the association between prenatal and postnatal paracetamol exposure and asthma development in a Central European sample of Czech children, suggesting possible additive effect of the both exposures. Furthermore, since aspirin had been used more widely during study data collection in Central Europe, we also compared asthma development for those exposed to paracetamol and aspirin. Methods We used data from 3329 children born in the 1990s as members of the prospective Czech European Longitudinal Study of Pregnancy and Childhood. Data about prenatal and postnatal paracetamol and aspirin exposure, and potential covariates were obtained from questionnaires completed by mothers. Data about incident asthma were obtained from paediatrician health records. Results 60.9% of children received paracetamol only postnatally, 1.5% only prenatally and 4.9% of children were exposed both during pregnancy and infancy. Prevalence of asthma in following population was 5% at 11 years. Being exposed to paracetamol both in prenatal and postnatal period was associated with asthma development (unadjusted OR 1.98, 95%CI 1.02 to 3.87). Being exposed only in the postnatal period was also significantly associated with increased risk of asthma. No association between prenatal exposure only and outcome was found. A higher but non-significant risk of asthma was observed for those whose mothers used paracetamol during pregnancy compared with those who used aspirin. Conclusions The main findings of this prospective birth cohort study add to previous observations linking prenatal and early postnatal paracetamol exposure to asthma development. However, the magnitude of effect is relatively modest, and therefore, we recommend paracetamol to remain the analgesic and antipyretic of choice throughout pregnancy and early childhood.

Links

CZ.02.1.01/0.0/0.0/16_013/0001761, interní kód MU
Name: RECETOX RI - OP VVV (Acronym: RECETOX RI)
Investor: Ministry of Education, Youth and Sports of the CR, Priority axis 1: Strengthening capacities for high-quality research
EF15_003/0000469, research and development project
Name: Cetocoen Plus
LM2015051, research and development project
Name: Centrum pro výzkum toxických látek v prostředí (Acronym: RECETOX RI)
Investor: Ministry of Education, Youth and Sports of the CR